Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Hashimoto

Showing results (1421-1430 of 1,505) with videos related to

Pageof 151
Sort By:
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1986
[Four cases of male breast cancer including one synchronously combined with gastric cancer]T Nakagoe, T Shimizu, M Ifuku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1986
[Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer]Y Nakamura, E Shimizu, F Hohjo, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial functionH Satoh, K Tsukamoto, Y Hashimoto, et al.
Journal of Virology|June 1, 1994
Analysis of AP-1 function in cellular transformation pathwaysT Suzuki, M Murakami, N Onai, et al.
Behavioural Brain Research|October 20, 2001
Histamine H1 receptor-mediated inhibition of potassium-evoked release of 5-hydroxytryptamine from mouse forebrainsL Z Son, K Yanai, J I Mobarakeh, et al.
The Journal of Antibiotics|May 20, 2000
Structures of ADP-ribosylated rifampicin and its metabolite: intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756N Morisaki, Y Hashimoto, K Furihata, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 26, 2000
Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatisT Imai, K Watanabe, Y Mikami, et al.
Peptides|January 1, 1986
PHI structural requirements for potentiation of glucose-induced insulin releaseC Yanaihara, Y Hashimoto, Y Takeda, et al.
Scandinavian Journal of Gastroenterology|July 1, 1997
Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural studyY Taguchi, M Kaito, E C Gabazza, et al.
Radiology|April 1, 1989
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit modelY Hashimoto, J M Stassen, B Leclef, et al.
Pageof 151

Showing results (1421-1430 of 1,505) with videos related to

Sort By:
Pageof 151
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1986
[Four cases of male breast cancer including one synchronously combined with gastric cancer]T Nakagoe, T Shimizu, M Ifuku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1986
[Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer]Y Nakamura, E Shimizu, F Hohjo, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial functionH Satoh, K Tsukamoto, Y Hashimoto, et al.
Journal of Virology|June 1, 1994
Analysis of AP-1 function in cellular transformation pathwaysT Suzuki, M Murakami, N Onai, et al.
Behavioural Brain Research|October 20, 2001
Histamine H1 receptor-mediated inhibition of potassium-evoked release of 5-hydroxytryptamine from mouse forebrainsL Z Son, K Yanai, J I Mobarakeh, et al.
The Journal of Antibiotics|May 20, 2000
Structures of ADP-ribosylated rifampicin and its metabolite: intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756N Morisaki, Y Hashimoto, K Furihata, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 26, 2000
Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatisT Imai, K Watanabe, Y Mikami, et al.
Peptides|January 1, 1986
PHI structural requirements for potentiation of glucose-induced insulin releaseC Yanaihara, Y Hashimoto, Y Takeda, et al.
Scandinavian Journal of Gastroenterology|July 1, 1997
Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural studyY Taguchi, M Kaito, E C Gabazza, et al.
Radiology|April 1, 1989
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit modelY Hashimoto, J M Stassen, B Leclef, et al.
Pageof 151